Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Epic American Credit and Bond Bubble Laboratory -- Ignore unavailable to you. Want to Upgrade?

To: Cogito Ergo Sum who wrote (22101)	11/20/2004 5:59:27 AM
From: Henry Niman	Respond to of 110194

Getting a flu shot this year wouldn't hurt. This is the first year that it has Fujian-like H3N2 for the northern hemisphere and so far all H3N2 isolates characterized this season in the US have been Fujian (and I suspect all outside of the US have also been Fujian-like - but a new variant, Wellington, has already begun to emerge in the south and Wellington will be in the vaccine being made for next season in the southern hemisphere). If the pandemic strain picks up some H3 or N2, the human shot might help. If you haven't had a shot (or the flu) lately, the human shot has three viruses, and the other influenza A is H1N1 and the antibodies against N1 might offer some protection against the N1 of H5N1. (Actually, I just saw an AP report indicating avian flu has just been detected in Maryland. No seroty[pe was given, but it was probably H5N2 or H7N2, so that Fujian H3N2 shot may not be a bad idea).